Last updated: April 29, 2025
Sponsor: Istituto Auxologico Italiano
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hormone Deficiencies
Severe Short Stature
Treatment
N/AClinical Study ID
NCT06294860
01C317
Ages 5-15 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
children of both sexes
age 5-15 years affected by isolated GH deficiency according to the criteria providedby note 39 AIFA for this pathology (short stature: ≤ -3 DS or ≤ -2 DS; growthrate/year ≤ -1.0 DS per age and sex evaluated at a distance of at least six months;GH peak at two different pharmacological stimulation tests < 8 ng/ml).
Exclusion
Exclusion Criteria:
- presence of organic hypothalamic-pituitary pathologies (diagnosed through encephalicNMR).
Study Design
Total Participants: 12
Study Start date:
June 19, 2023
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
Istituto Auxologico Italiano
Milano, 20145
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.